Share this Story : Drug used to slow ALS progression shows promise in treating deadly brain cancer Copy Link Email X Reddit Pinterest LinkedIn Tumblr Breadcrumb Trail Links Local News Drug used to slow ALS progression shows promise in treating deadly brain cancer The drug — called edaravone — shows promise in suppressing the self-renewing cancerous stem cells that challenge treatment of glioblastoma. Get the latest from Elizabeth Payne straight to your inbox Sign Up Author of the article: Elizabeth Payne Published Oct 27, 2024 • 3 minute read Join the conversation You can save this article by registering for free here . Or sign-in if you have an account.
Dr. Arezu Jahani-Asl is leading research at uOttawa that has found a drug currently used for the neurological disorder ALS shows promise for treating the deadly brain tumour glioblastoma. PHOTO COURTESY OF UOTTAWA Article content An old drug could bring new hope for people suffering from the most common, and deadly, primary brain tumour in adults.
uOttawa researcher Dr. Arezu Jahani-Asl, who holds a Canada Research Chair in Neurobiology of Disease, leads a team that has found a drug currently used to slow progression of the neurological disorder ALS (amyotrophic lateral sclerosis) shows promise in treating glioblastoma. Advertisement 2 Story continues below This advertisement has not loaded yet, but your article continues below.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your .